Press Release: Blood testing is very helpful as far as the detection of mood disorders are concerned. As a result, the diagnosis may help the medical community come up with better treatments so that the condition can be treated in a better way.

The fact is that as of now, there are no blood tests that are recommended for mood disorders. And the fact is that if you will ask the patients to rate the seriousness of their symptoms and on the clinicians impression, then the whole procedure will minimize the chances of effective treatment and the chances for inventing a new drug will get reduced.

Researchers from Indiana University School of Medicine have come up with a new way to help identify blood biomarkers so that they can determine the mood state in a better way.

The study shows topping the list of candidate blood biomarker genes, that there are in totality five genes that are involved in myelination. Six genes are involved in growth factor signaling. The fact is that all the genes are responsible for having differential expression in the brains of patients that are suffering mood disorders.

As fas as the score is concerned, that was based on a panel of ten top candidate biomarkers — it goes like this: five are responsible for high mood, five are responsible for low mood — shows sensitivity and specificity for high mood and low mood states, in two separate studies.

According to the research, it has been suggested that the blood biomarkers may offer an unexpectedly informative view that is linked with brain functioning and the actual state of the disease. It has been also shown in the result that an intriguing overlap between genes involved in cancer biology and those involved in mood regulation.